400-859-2883
Your location:Home >News center >Industry News

Industry News

05-112021

CDK4/6 Inhibitors for Treatment of Advanc…

There are three CDK4/6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib approved by FDA to treat Advanced Breast Cancer.

CDK4/6 Inhibitors for Treatment of Advanced Breast Cancer